Pranoprofen
データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
52549-17-4CC(C(=O)O)c1ccc2c(c1)Cc1cccnc1O2TVQZAMVBTVNYLA-UHFFFAOYSA-NPranoprofen is a pyridochromene.
52549-17-4DTXSID1023497CHEMBL367463CHEBI:32040安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P264+P265, P270, P280, P301+P316, P302+P352, P305+P351+P338, P321, P330, P332+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 3 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug-Induced Liver Injury Severity and Toxicity (DILIst)
Pranoprofen
DILI Positive
DOI:10.1016/j.drudis.2019.09.022
S01BC09
S - Sensory organs
QS - Sensory organs
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.
用途プロピオン酸系化合物です。 シクロオキシゲナーゼ(COX)を阻害し、プ ロスタグランジン生合成抑制作用を示します。
使用Pranoprofen is an anti-inflammatory used in ophthalmology.
一般的な説明Pranoprofen is an arylalkanoic acid and a non-steroidal anti-inflammatory drug.
読み込み中…
化学的特性Off-White Solid